Carboplatin Accord 10 mg/ml

DRUG2 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Universitair Ziekenhuis Gent

Conditions

metastatic non-small-cell lung canceroesophageal canceroesophagogastric junction cancer

Phase 1

A phase 1b study of an autologous dendritic cell immunotherapy in combination with anti-programmed death-1 treatment in patients with metastatic non-small-cell lung cancer (DARE-LUNG)

Not yet recruitingCTIS2025-521577-13-00

Universitair Ziekenhuis Gentmetastatic non-small-cell lung cancer

Target: 64Updated: 2025-09-11

Phase 2

Total Neoadjuvant Therapy for lymph node-positive adenocarcinoma of the OESophagus and oesophagogastric junction: TNT-OES-2 trial

RecruitingCTIS2025-521158-40-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)oesophageal cancer, oesophagogastric junction cancer

Start: 2025-09-12Target: 12Updated: 2025-08-27